Acromegaly: Treatment with somatostatin analogs

Acromegaly: Treatment with somatostatin analogs

Bibliographic Details
Main Authors:	Karavitaki, N, Wass, J
Format:	Journal article
Published:	2005

Similar Items

Pegvisomant: a new treatment modality for acromegaly.
by: Karavitaki, N, et al.
Published: (2004)

AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
by: Chahal, H, et al.
Published: (2010)

Pituitary imaging using a labelled somatostatin analogue in acromegaly.
by: Ur, E, et al.
Published: (1992)

Acute octreotide suppression test (100 mu g sc): a valuable tool for predicting the long-term response to the long-acting somatostatin analogs in patients with active acromegaly
by: Karavitaki, N, et al.
Published: (2005)

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
by: Chahal, H, et al.
Published: (2011)

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
by: Karavitaki, N, et al.
Published: (2005)

New treatments for acromegaly.
by: Wass, J, et al.
Published: (1998)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
by: Wass, J
Published: (1997)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
by: Grossman, A, et al.
Published: (1985)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
by: Grossman, A, et al.
Published: (1986)

Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?
by: Fernandez, A, et al.
Published: (2008)

Hypercalcaemia in acromegaly is not always due to men-1
by: Zabuliene, L, et al.
Published: (2005)

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
by: Chahal, H, et al.
Published: (2012)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
by: Jenkins, P, et al.
Published: (2000)

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999)

Long-term effects of radiotherapy for acromegaly.
by: Wass, J
Published: (1996)

Radiotherapy in acromegaly: a protagonists viewpoint.
by: Wass, J
Published: (2003)

Investigation protocol: acromegaly and its investigation.
by: Duncan, E, et al.
Published: (1999)

Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
by: Wass, J
Published: (2003)

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
by: Karavitaki, N, et al.
Published: (2008)

Antiangiogenic effects of somatostatin analogues.
by: García de la Torre, N, et al.
Published: (2002)

Acromegaly, colonic polyps and carcinoma.
by: Jenkins, P, et al.
Published: (1997)

Guidelines for acromegaly management.
by: Melmed, S, et al.
Published: (2002)

Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
by: Turner, H, et al.
Published: (2004)

The pathology of median neuropathy in acromegaly.
by: Jenkins, P, et al.
Published: (2000)

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas.
by: Larkin, S, et al.
Published: (2013)

The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly.
by: Karavitaki, N, et al.
Published: (2009)

Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.
by: Turner, H, et al.
Published: (1999)

Acromegaly or chronic renal failure: a diagnostic dilemma.
by: Wong, N, et al.
Published: (1997)

Criteria for cure of acromegaly: a consensus statement.
by: Giustina, A, et al.
Published: (2000)

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
by: Ahmed, S, et al.
Published: (1999)

The role of somatostatin analogues in the treatment of neuroendocrine tumours.
by: Grozinsky-Glasberg, S, et al.
Published: (2008)

Acromegaly: Beyond surgery.
by: Thanabalasingham, G, et al.
Published: (2013)

Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
by: Kaltsas, G, et al.
Published: (2001)

Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
by: Wass, J
Published: (1997)

Menstrual irregularity in women with acromegaly.
by: Kaltsas, G, et al.
Published: (1999)

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly.
by: Pereira, E, et al.
Published: (2010)

Uterine leiomyomata in women with acromegaly
by: Kaltsas, G, et al.
Published: (2000)

Guidelines for acromegaly management: an update.
by: Melmed, S, et al.
Published: (2009)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
by: Kaltsas, G, et al.
Published: (2005)